Head and Neck Carcinoma, Other — Trials

Head and Neck Carcinoma, Other — Trials · CancerIndex

Clinical trials

Registered studies

128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 35
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01896479	A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer(EXAMINER)	active not recruiting	Phase 4	247	ExelixisINDUSTRY	14	Sep 2, 2025	clinicaltrials
NCT05830500	Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma	recruiting	Phase 4	360	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY	1	Jul 25, 2023